These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Hyperkalemia]. Le Gall JR Nouv Presse Med; 1974 May; 3(21):1391-2. PubMed ID: 4848890 [No Abstract] [Full Text] [Related]
25. Acute hyperkalemia induced by hyperglycemia: hormonal mechanisms. Goldfarb S; Cox M; Singer I; Goldberg M Ann Intern Med; 1976 Apr; 84(4):426-32. PubMed ID: 769633 [TBL] [Abstract][Full Text] [Related]
26. [Diagnosis and treatment of disorders of the potassium balance with special reference to infusion therapy]. Düsing R; Kramer HJ Infusionsther Klin Ernahr; 1975 Dec; 2(6):409-10,413-6. PubMed ID: 1205585 [TBL] [Abstract][Full Text] [Related]
27. Glucose modulation of the disposal of an acute potassium load in patients with end-stage renal disease. Allon M; Dansby L; Shanklin N Am J Med; 1993 May; 94(5):475-482. PubMed ID: 8498392 [TBL] [Abstract][Full Text] [Related]
28. Fluoridation: a clinician's experience. Waldbott GL South Med J; 1980 Mar; 73(3):301-6. PubMed ID: 7361130 [TBL] [Abstract][Full Text] [Related]
29. [Hyperkalemic emergency: causes, diagnosis and therapy]. Tamm M; Ritz R; Thiel G; Truniger B Schweiz Med Wochenschr; 1990 Jul; 120(29):1031-6. PubMed ID: 2374893 [TBL] [Abstract][Full Text] [Related]
30. Fluoride-induced chronic renal failure. Lantz O; Jouvin MH; De Vernejoul MC; Druet P Am J Kidney Dis; 1987 Aug; 10(2):136-9. PubMed ID: 3605090 [TBL] [Abstract][Full Text] [Related]
32. [The inhibition of potassium loss of fluoride-poisoned erythrocytes by chelating agents]. LEPKE S; PASSOW H Pflugers Arch Gesamte Physiol Menschen Tiere; 1960; 271():389-96. PubMed ID: 14415893 [No Abstract] [Full Text] [Related]
33. Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia. Allon M; Takeshian A; Shanklin N Kidney Int; 1993 Jan; 43(1):212-7. PubMed ID: 8433561 [TBL] [Abstract][Full Text] [Related]
35. Diagnosis and treatment of acute fluoride toxicity. Bayless JM; Tinanoff N J Am Dent Assoc; 1985 Feb; 110(2):209-11. PubMed ID: 3856600 [TBL] [Abstract][Full Text] [Related]
36. Acute and chronic cardiovascular effects of hyperkalemia: new insights into prevention and clinical management. McCullough PA; Beaver TM; Bennett-Guerrero E; Emmett M; Fonarow GC; Goyal A; Herzog CA; Kosiborod M; Palmer BF Rev Cardiovasc Med; 2014; 15(1):11-23. PubMed ID: 24762462 [TBL] [Abstract][Full Text] [Related]
37. Nonazotemic hyperkalemia with renal and extrarenal defects in potassium transport: association with high levels of digoxin-like immunoreactive factor. Szylman P; Wolach B; Winaver J; Panett R; Cohen P; Shenkman L; Better OS J Lab Clin Med; 1990 Sep; 116(3):315-26. PubMed ID: 2205695 [TBL] [Abstract][Full Text] [Related]
38. Lethal hyperkalemia associated with severe hyperglycemia in diabetic patients with renal failure. Montoliu J; Revert L Am J Kidney Dis; 1985 Jan; 5(1):47-8. PubMed ID: 3966469 [TBL] [Abstract][Full Text] [Related]
39. Prognostic implications of hyperkalemia in toad toxin intoxication. Chi HT; Hung DZ; Hu WH; Yang DY Hum Exp Toxicol; 1998 Jun; 17(6):343-6. PubMed ID: 9688359 [TBL] [Abstract][Full Text] [Related]
40. Potassium homeostasis and hyperkalemic syndromes. Clark BA; Brown RS Endocrinol Metab Clin North Am; 1995 Sep; 24(3):573-91. PubMed ID: 8575410 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]